Change of 374.74% for AXIM BIOTECHNOLOGIES INC (OTCMKTS:AXIM)’s shares shorted was showed. FINRA published in April AXIM’s total 227,400 shares shorted. The up change of 374.74% from 47,900 shares was reported. With Average volume 861,300, AXIM’s former position will take 0 days to restore.
AXIM hit $1.4785 during the last trading session after $0.0185 change.AXIM Biotechnologies, Inc. has volume of 50,261 shares. Since April 5, 2018 AXIM has 0.00% and is . The stock underperformed the S&P500 by 4.37%.
AXIM Biotechnologies, Inc., a biotechnology company, focuses on the treatment of pain, spasticity, anxiety, and other medical disorders with the application of cannabinoids based products.The firm is valued at $89.20 million. It also focuses on the research, development, and production of pharmaceutical, nutraceutical, oral health, and cosmetic products, as well as procurement of genetically and nano-controlled active ingredients.Currently it has negative earnings. The firm was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014.
For more AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) news posted briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Rush for pot patents in full swing – Reuters – Seeking Alpha” posted on November 30, 2018, “Marijuana Stocks: Short AXIM Biotechnologies…If You Can Borrow And Finance The Shares – Seeking Alpha” on November 23, 2016, “Revive Therapeutics provides corporate update – Seeking Alpha” with a publish date: August 28, 2018, “Medical Marijuana Inc.: Too Risky, Avoid For Now – Seeking Alpha” and the last “Axim Biotechnologies: A Great Stock To Sell Short – Seeking Alpha” with publication date: May 02, 2017.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.